Literature DB >> 20424903

Generalized seizures aggravated by levetiracetam in an adult patient with phenylketonuria.

Nese Dericioglu1, Serap Saygi.   

Abstract

Phenylketonuria (PKU) is one of the most common inherited metabolic disorders, which is characterized by excessive accumulation of phenylalanine (Phe) in tissues. Generalized seizures occur in 25% of the patients. Little is known about seizures and their treatment in adult PKU patients, and information with newer antiepileptic drugs is lacking. Here we report an adult patient who developed generalized seizures later in life, despite strict dietary control, and whose seizures were aggravated by levetiracetam (LEV). Convulsions ceased after discontinuation of LEV and the patient has been seizure free on topiramate 125 mg/day.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20424903     DOI: 10.1007/s11011-010-9197-7

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  12 in total

1.  Complete reversal of moderate/severe brain MRI abnormalities in a patient with classical phenylketonuria.

Authors:  J H Walter; F White; J E Wraith; J P Jenkins; B P Wilson
Journal:  J Inherit Metab Dis       Date:  1997-07       Impact factor: 4.982

Review 2.  Adult care in phenylketonuria and hyperphenylalaninaemia: the relevance of neurological abnormalities.

Authors:  D P Brenton; J Pietz
Journal:  Eur J Pediatr       Date:  2000-10       Impact factor: 3.183

3.  Clinical analysis of West syndrome associated with phenylketonuria.

Authors:  Z Zhongshu; Y Weiming; F Yukio; Z Cheng-LNing; W Zhixing
Journal:  Brain Dev       Date:  2001-11       Impact factor: 1.961

4.  Neurological deterioration in adult phenylketonuria.

Authors:  D Villasana; I J Butler; J C Williams; S M Roongta
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

5.  Phenylketonuria: an inborn error of phenylalanine metabolism.

Authors:  Robin A Williams; Cyril D S Mamotte; John R Burnett
Journal:  Clin Biochem Rev       Date:  2008-02

6.  Epilepsy in phenylketonuria: a complex dependence on serum phenylalanine levels.

Authors:  Anatoly E Martynyuk; Deniz A Ucar; Dawn D Yang; Wendy M Norman; Paul R Carney; Donn M Dennis; Philip J Laipis
Journal:  Epilepsia       Date:  2007-05-01       Impact factor: 5.864

7.  Brain MRI changes in phenylketonuria. Associations with dietary status.

Authors:  A J Thompson; S Tillotson; I Smith; B Kendall; S G Moore; D P Brenton
Journal:  Brain       Date:  1993-08       Impact factor: 13.501

8.  The risk of paradoxical levetiracetam effect is increased in mentally retarded patients.

Authors:  Anna Szucs; Zsófia Clemens; Rita Jakus; György Rásonyi; Daniel Fabó; András Holló; Gábor Barcs; Anna Kelemen; József Janszky
Journal:  Epilepsia       Date:  2008-07       Impact factor: 5.864

Review 9.  Adult phenylketonuria.

Authors:  W B Hanley
Journal:  Am J Med       Date:  2004-10-15       Impact factor: 4.965

10.  EEG in phenylketonuria. Attempt to establish clinical importance of EEG changes.

Authors:  P T Gross; S Berlow; V E Schuett; R G Fariello
Journal:  Arch Neurol       Date:  1981-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.